Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function

Clinical trial NCT03186495 · COMPLETED

Trial details

NCT number

NCT03186495

Sponsor

Novo Nordisk A/S

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-06-20

Primary completion

2018-05-17

Enrollment

44

View on ClinicalTrials.gov